HCM — HUTCHMED (China) Share News
0.000.00%
Last trade - 00:00
- £2.28bn
- £1.75bn
- $838.00m
- 26
- 10
- 72
- 25
REG - Hutchmed China Ltd - Exercise of Share Options by a Director
AnnouncementREG - Hutchmed China Ltd - Interim Results and Business Updates
AnnouncementRCS - Hutchmed China Ltd - Breakthrough Therapy Designation for Fruquintinib
AnnouncementREG - Hutchmed China Ltd - Changes to Board and Technical Committee
AnnouncementRCS - Hutchmed China Ltd - Phase 1 Study of HMPL-415 Initiated
AnnouncementREG - Hutchmed China Ltd - Blocklisting Six Monthly Return
AnnouncementREG - Hutchmed China Ltd - HUTCHMED to Announce 2023 Half-Year Results
AnnouncementREG - Hutchmed China Ltd - Phase III FRESCO-2 Results in The Lancet
AnnouncementREG - Hutchmed China Ltd - MAA of Fruquintinib Validated by the EMA
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Highlights Presentations at EHA and ICML
AnnouncementREG - Hutchmed China Ltd - LTIP and Share Option Scheme
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
AnnouncementREG - Hutchmed China Ltd - Fruquintinib NDA Granted Priority Review by FDA
AnnouncementRCS - Hutchmed China Ltd - HUTCHMED Highlights Presentations at ASCO 2023
AnnouncementREG - Hutchmed China Ltd - Standard form for notification of major holdings
AnnouncementREG - Hutchmed China Ltd - Annual General Meeting Poll Results
AnnouncementREG - Hutchmed China Ltd - Board of Directors and Board Committee Membership
AnnouncementREG - Hutchmed China Ltd - Appointment of Independent NED
AnnouncementREG - Hutchmed China Ltd - Total Voting Rights
Announcement